AbbVievsWest Pharmaceutical Services

ABBV and WST stock compared: price, dividend, valuation and results, from SEC filings.

WST

West Pharmaceutical Services, Inc.

$419.71

Value $30.2B

+0.79%
WST's page

AbbVie (ABBV) has a market value of $523B and West Pharmaceutical Services (WST) $30.2B. Over the last year, with dividends, ABBV moved +31.2% and WST +61.1%. The P/E is 50.8 for ABBV and 47.3 for WST. Dividend yield: ABBV 2.34%, WST 0.22%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$523B

    WST$30.2B

    ABBV is 17 times WST

  • Revenue, 12 months

    ABBV$66.0B

    WST$3.4B

    ABBV is 19 times WST

  • Net income, 12 months

    ABBV$10.3B

    WST$639M

    ABBV is 16 times WST

  • Operating margin

    ABBV32.2%

    WST23.0%

    9.2 points apart

  • ROIC

    ABBV25.7%

    WST19.0%

    6.7 points apart

  • P/E

    ABBV50.8

    WST47.3

    ABBV is 1.1 times WST

  • Dividend yield

    ABBV2.3%

    WST0.2%

    2.1 points apart

  • 5-year return

    ABBV+202.9%

    WST+0.7%

    202.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+202.9%

WST+0.7%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsWSTWith dividends
1 year since November 14, 2025+31.2%Price +27.4%+61.1%Price +60.6%
3 years since November 16, 2023+136.7%+33.3% a yearPrice +114.1%+23.0%+7.1% a yearPrice +21.9%
5 years since November 15, 2021+202.9%+24.8% a yearPrice +153.3%+0.7%+0.1% a yearPrice -0.7%
10 years since November 16, 2016+623.1%+21.9% a yearPrice +381.0%+446.7%+18.5% a yearPrice +427.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieWSTWest Pharmaceutical Services

Valuation

ABBVWST
Valuation
Price$296.00$419.71
Market value$523B$30.2B
Enterprise value (EV)$593B$30.0B
P/E50.847.3
P/E, 5-year median57.044.7
P/B–10.2
EV/EBIT28.038.4
Free cash flow yield3.6%1.5%

Results and growth

ABBVWST
Results and growth
Revenue, 12 months$66.0B$3.4B
Net income, 12 months$10.3B$639M
Free cash flow, 12 months$18.9B$453M
Earnings per share, 12 months$5.81$8.91
Revenue growth, year on year8.6%6.3%
Revenue growth a year, past+5.9%over 5 years+7.4%over 5 years
EPS growth a year, past-2.8%over 5 years+8.2%over 5 years

Margins and returns on capital

ABBVWST
Margins and returns on capital
Gross margin73.7%37.6%
Operating margin32.2%23.0%
Net margin15.7%18.8%
ROIC25.7%19.0%
ROE–21.1%

Balance sheet

ABBVWST
Balance sheet
Cash$10.8B$464M
Total debt$80.9B$314M
Net debt / EBITDA3.2-0.3
Interest cover7.1×96.3×

Dividends and buybacks

ABBVWST
Dividends and buybacks
Dividend yield2.3%0.2%
Dividend per share, 12 months$6.92$0.92
Dividend growth a year, past+6.6%over 5 years+5.4%over 5 years
Buyback yield0.2%0.4%
Shareholder yield2.5%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or WST

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or West Pharmaceutical Services?

By market value, AbbVie ($523B) is about 17.3 times West Pharmaceutical Services ($30.2B), at today's prices.

How did ABBV and WST stock do over the last 10 years?

Since November 16, 2016, ABBV's price moved +381.0% and WST's +427.7%. With dividends: ABBV +623.1% (+21.9% a year), WST +446.7% (+18.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or WST?

The dividend yield at today's price is 2.34% for AbbVie and 0.22% for West Pharmaceutical Services. Over the last twelve months they paid $6.92 and $0.92 per share.

What is the P/E of ABBV and WST?

At today's price, the P/E is 50.8 for ABBV and 47.3 for WST. The median of the last five years was 57.0 and 44.7, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or West Pharmaceutical Services?

Over the last twelve months, the net margin was 15.7% for AbbVie and 18.8% for West Pharmaceutical Services, and the operating margin 32.2% and 23.0%. Revenue was $66.0B and $3.4B.

Which is the better investment, AbbVie or West Pharmaceutical Services?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.